2016
Antenatal Betamethasone for Women at Risk for Late Preterm Delivery
Gyamfi-Bannerman C, Thom E, Blackwell S, Tita A, Reddy U, Saade G, Rouse D, McKenna D, Clark E, Thorp J, Chien E, Peaceman A, Gibbs R, Swamy G, Norton M, Casey B, Caritis S, Tolosa J, Sorokin Y, VanDorsten J, Jain L. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. Obstetrical & Gynecological Survey 2016, 71: 453-455. DOI: 10.1097/01.ogx.0000489576.69844.54.Peer-Reviewed Original ResearchLate preterm periodPreterm periodMaternal-Fetal Medicine Units NetworkEunice Kennedy Shriver National InstituteLate preterm deliveryAdministration of betamethasoneAntenatal betamethasoneNeonatal morbidityPreterm deliveryMulticenter trialClinical centersChildhood complicationsChild healthNational InstituteBetamethasoneWomenRiskMorbidityComplicationsNewbornsInfantsAdministrationTrials
1992
Characterization of a direct effect of phorbol myristate acetate on human neutrophil cell membrane using 31D8 monoclonal antibody
Woronick C, Maderazo E, Anthony M, Krause P, Sha'afi R. Characterization of a direct effect of phorbol myristate acetate on human neutrophil cell membrane using 31D8 monoclonal antibody. Journal Of Leukocyte Biology 1992, 51: 289-295. PMID: 1541911, DOI: 10.1002/jlb.51.3.289.Peer-Reviewed Original ResearchConceptsPolymorphonuclear neutrophilsAntigen expressionLate effectsAlpha-tocopherolProtein kinase CInhibitor of cyclooxygenaseNormal polymorphonuclear neutrophilsKinase CPhorbol myristate acetateNeutrophil cell membraneProtective effectConcentrations of PMADirect effectHuman neutrophilsMonoclonal antibodiesMyristate acetateInhibitory affectRapid initiationMembrane stabilizationBetamethasoneNeutrophilsOxidative burstInactive analoguePMAPMA effect
1987
The Biochemistry of Fetal Lung Development
Kresch M, Gross I. The Biochemistry of Fetal Lung Development. Clinics In Perinatology 1987, 14: 481-507. PMID: 3311536, DOI: 10.1016/s0095-5108(18)30747-4.ChaptersConceptsSurfactant therapyLung complianceLung maturationAdministration of betamethasoneEffects of glucocorticoidsFetal lung developmentNumber of alveoliGlucocorticoid therapyFetal rabbitsLung developmentTherapyAnimal dataTissue complianceHormonal enhancementAdditive effectAdministrationComplianceMaturationRDSMorbidityBetamethasoneGlucocorticoidsLungMortalitySteroidsThe Effect of Betamethasone on Neonatal Neutrophil Chemotaxis
Fuenfer M, Herson V, Raye J, Woronick C, Eisenfeld L, Ingardia C, Block C, Krause P. The Effect of Betamethasone on Neonatal Neutrophil Chemotaxis. Pediatric Research 1987, 22: 150-153. PMID: 3658539, DOI: 10.1203/00006450-198708000-00009.Peer-Reviewed Original ResearchConceptsEffect of betamethasoneBacterial infectionsNewborn infantsPMN functionMaternal glucocorticoid administrationNeonatal PMN functionFetal lung maturationMigration of PMNRandom migrationConcentrations of betamethasonePMN random migrationSignificant clinical importanceBetamethasone administrationGlucocorticoid administrationPregnant womenLung maturationNeutrophil functionStandard doseCord bloodNeutrophil chemotaxisAntiinflammatory agentsClinical importanceImportant causeImmune systemBetamethasone
1985
1094 THE EFFECT OF BETAMETHASONE ON THE CHEMOTACTIC RESPONSE OF NEONATAL NEUTROPHILS
Fuenfer M, Ingardia C, Raye J, Block C, Krause P. 1094 THE EFFECT OF BETAMETHASONE ON THE CHEMOTACTIC RESPONSE OF NEONATAL NEUTROPHILS. Pediatric Research 1985, 19: 293-293. DOI: 10.1203/00006450-198504000-01124.Peer-Reviewed Original ResearchEffect of betamethasoneMaternal steroid administrationPerinatal bacterial infectionHealthy term neonatesFetal lung maturationRisk of infectionSteroid administrationTerm neonatesHost defense systemNeonatal neutrophilsLung maturationNeutrophil functionCord bloodPMN functionNeonatal PMNTherapeutic concentrationsPMN chemokinesisBacterial infectionsBetamethasoneNeonatesPMN motilitySignificant inhibitionRandom migrationMicropore filtersFurther compromise
1984
COMBINED HORMONAL THERAPY MAY DECREASE THE TIME NEEDED FOR INDUCTION OF LUNG SURFACTANT PRODUCTION
Moya F, Gross I. COMBINED HORMONAL THERAPY MAY DECREASE THE TIME NEEDED FOR INDUCTION OF LUNG SURFACTANT PRODUCTION. Pediatric Research 1984, 18: 142-142. DOI: 10.1203/00006450-198404001-00296.Peer-Reviewed Original ResearchLung surfactant productionHormonal therapyFetal ratsDay 20Surfactant productionPregnant Sprague-Dawley ratsFetal lung maturationSprague-Dawley ratsCombination of hormonesMaternal administrationCombined therapyLung maturationMaternal injectionLung mincesThyroid hormonesCholine incorporationSurfactant synthesisTherapyRatsStatistical significanceRecent evidenceCorticosteroidsBetamethasoneFetusesAdditive effect
1979
Effects of betamethasone on phospholipid content, composition and biosynthesis in the fetal rabbit lung
Rooney S, Gobran L, Marino P, Maniscalco W, Gross I. Effects of betamethasone on phospholipid content, composition and biosynthesis in the fetal rabbit lung. Biochimica Et Biophysica Acta 1979, 572: 64-76. PMID: 216408, DOI: 10.1016/0005-2760(79)90200-5.Peer-Reviewed Original ResearchConceptsLung lavageFetal lung lavageFetal lung slicesAdministration of betamethasoneEffect of betamethasoneFetal lung maturationFetal rabbit lungPhosphatidylcholine/sphingomyelin ratioLung glycogenBetamethasone administrationLung maturationPregnant rabbitsDays gestationFetal lungLung slicesRabbit lungsStress-induced accelerationDirect administrationSphingomyelin ratioSurfactant phospholipidsBetamethasoneAdministrationRate of incorporationSurfactant productionLavage
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply